Abingdon Health Plc (ABDX.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Abingdon Health Plc
Address
York Biotech Campus
York, YO41 1LZ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 19 0440 6050
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
113
First IPO Date
December 15, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Thomas Edward Hayes | Secretary, Chief Financial Officer & Director | 69,000 | 1976 |
| Chris Henry Francis Yates | President of & Director Abingdon Health USA Inc. | 217,000 | 1974 |
| Christopher William Hand | Executive Chairman | 229,000 | 1961 |
| Mark Jones | Chief Operating Officer | 0 | N/A |
| Nina Garrett | Chief Technical Officer | 0 | N/A |
| Laura Towse | Controller | 0 | N/A |
Description
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
